Communicating the safety essentials of oral anticoagulant therapy.
Lamarche
Kimberley
K
Advanced Nursing Practice Program, Athabasca University, Athabasca, Alberta, Canada. lamarche@athabasca.ca
Heale
Roberta
R
D000284:Administration, Oral; D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D003142:Communication; D003152:Community Health Nursing / Q000379:methods*; D004334:Drug Administration Schedule; D004347:Drug Interactions; D016903:Drug Monitoring / Q000379:methods / Q000451:nursing; D005260:Female; D006261:Headache / Q000139:chemically induced; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000627:therapeutic use; D006699:Home Care Services; D006801:Humans; D007400:Interprofessional Relations; D024802:Nurse's Role; D009723:Nurse-Patient Relations; D010353:Patient Education as Topic / Q000379:methods*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D017751:Safety Management / Q000379:methods*; D014012:Tinnitus / Q000139:chemically induced; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin; D006493:Heparin